CTIS2022-500902-16-00招募中1 期
PH-FAPGA-01/22
Philogen S.p.A.0 个研究点目标入组 20 人开始时间: 2022年7月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A Phase I, open-label, randomized, two period, cross-over study in healthy subjects to assess the bioavailability of different formulations of deucrictibant administered as single dose under fasting condition.Hereditary angioedema (HAE)MedDRA version: 23.1Level: PTClassification code: 10019860Term: Hereditary angioedema Class: 100000004850CTIS2024-511196-15-00Pharvaris Netherlands B.V.14
招募中
1 期
Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM534 Administered Intravenously to Patients with Advanced Solid TumorsAdvanced Solid TumorsCTIS2024-513056-15-00Pharma Mar S.A.30
进行中（未招募）
1 期
A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet administered once daily on the pharmacokinetics of the P-gp substrate digoxin and the BCRP substrate rosuvastatin, administered as a drug cocktailHereditary angioedemaCTIS2024-514713-35-0014
进行中（未招募）
1 期
Randomised, crossover bioavailability clinical trial of oral minoxidil 1 mg, after single and multiple dose administration to healthy volunteers under fasting conditionsAndrogenetic alopeciaCTIS2023-503796-14-00Industrial Farmaceutica Cantabria S.A.14
招募中
1 期
Phase 1 study in Staphylococcus aureus endocarditisInfectious S. aureus endocarditisMedDRA version: 20.1Level: LLTClassification code: 10041937Term: Staphylococcus aureus endocarditis Class: 10021881CTIS2023-505413-25-00Phaxiam Therapeutics12